Plasma N-Glycome Signature of Down Syndrome
Authors:
- 14 September 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 14 (10) , 4232-4245
Abstract
In recent years, plasma N-glycans have emerged as biomarkers for health and disease. Here, we studied N-glycomic changes in Down Syndrome (DS). Because of the progeroid phenotype of DS, we focused on the dissection of syndrome- and aging-associated glycomic changes, as well as the interaction thereof. We analyzed the plasma N-glycome of 76 DS persons, 37 siblings (DSS), and 42 mothers (DSM) of DS persons by DNA-sequencer-aided, fluorophore-assisted-carbohydrate-electrophoresis, as well as by matrix-assisted laser desorption ionization-time-of-flight-mass spectrometry (MALDI-TOF-MS). The results showed an overall decrease of galactosylation and α2,3 sialylation, a concomitant increase of the level of fucosylated N-glycans as well as of monogalactosylated diantennary N-glycans in DS, while the GlycoAgeTest and the ratio of the two core-fucosylated, monogalactosylated diantennary isomers (galactose positioned on α1,6 arm versus α1,3 arm) were the strongest DS discriminators. Hypogalactosylation is a characteristic of both DS and aging of control individuals. A decrease in α2,3-sialylated species is also common to DS and aging of controls. However, regarding to α2,6-sialylated tri- and tetragalactosylated N-glycan species, we found those to be lowered in DS but showed an increase with age in the same persons, while these glycans were not affected by aging in control individuals. In conclusion, we identified specific glycomic changes associated with DS, aging in DS, as well as aging in controls, identifying glycomic features in line with accelerated aging in DS. Notably, our data demonstrate an aging phenotype in DS which only in part overlaps with aging in controls but reveals DS-specificity.Keywords
Funding Information
- Seventh Framework Programme (259679, 278535)
This publication has 61 references indexed in Scilit:
- N-glycans in liver-secreted and immunoglogulin-derived protein fractionsJournal of Proteomics, 2012
- High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human PopulationsMolecular & Cellular Proteomics, 2011
- Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adultsHuman Molecular Genetics, 2011
- Inflammatory and Immunological parameters in adults with Down syndromeImmunity & Ageing, 2011
- Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006Birth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human LongevityPLOS ONE, 2010
- The N-Glycome of Human PlasmaJournal of Proteome Research, 2010
- Health Conditions Associated with Aging and End of Life of Adults with Down Syndrome2010
- Intrinsic Abnormalities of Lymphocyte Counts in Children with Down SyndromeThe Journal of Pediatrics, 2005
- Risk of Death for Children with Down Syndrome and SepsisThe Journal of Pediatrics, 2005